Seelos’ Gene Therapy Acquisition For Parkinson’s Disease Brings Another Shot On Goal – Seeking Alpha

Seelos’ Gene Therapy Acquisition For Parkinson’s Disease Brings Another Shot On Goal – Seeking Alpha
Seelos' Gene Therapy Acquisition For Parkinson's Disease Brings Another Shot On Goal  Seeking AlphaSeelos Therapeutics licensed gene therapy product SLS-004 from Duke University to treat patients with Parkinson's Disease. The global PD market is expected ... read more
Source: Google NewsPublished on 2019-07-10